KPIs & Operating Metrics(New)
Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPreferred SharesReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Markel (MKL) Cash & Equivalents (2016 - 2025)

Markel (MKL) has disclosed Cash & Equivalents for 16 consecutive years, with $4.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 4.55% to $4.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $4.0 billion, a 4.55% increase, with the full-year FY2024 number at $3.7 billion, down 1.45% from a year prior.
  • Cash & Equivalents was $4.0 billion for Q3 2025 at Markel, up from $3.7 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.2 billion in Q1 2025 to a low of $3.5 billion in Q3 2022.
  • A 5-year average of $3.9 billion and a median of $3.9 billion in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: fell 23.88% in 2021, then rose 4.55% in 2025.
  • Markel's Cash & Equivalents stood at $4.0 billion in 2021, then increased by 4.0% to $4.1 billion in 2022, then fell by 9.44% to $3.7 billion in 2023, then dropped by 1.45% to $3.7 billion in 2024, then increased by 9.65% to $4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MKL's Cash & Equivalents are $4.0 billion (Q3 2025), $3.7 billion (Q2 2025), and $4.2 billion (Q1 2025).